Clinical Trials Sponsored by Jiangsu Famous Medical Technology Co., Ltd.

Total 381 results

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Nanjing Medical University

Completed

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B (PEG-Tα1)

Hepatitis B, Chronic

China
Guangxi Medical University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Hepatocellular Carcinoma

China
Allife Medical Science and Technology Co., Ltd.

Not yet recruiting

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
Shanghai Bluesail Boyuan Medical Technology Co....

Recruiting

Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Coronary Artery Disease | Intravascular Lithotripsy

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Leukemia
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Digestive System Neoplasms | Advanced Solid Tumors | Pancreatic Cancer Resectable | Colorectal (Colon or Rectal) Cancer

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

Gastric Cancer | Pancreatic Cancer | Advanced Solid Tumors | Esophagogastric Junction Cancer

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Neoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphoma, Mantle-Cell
Beijing Immunochina Medical Science & Technology...

Completed

Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T)

AML

China
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd.

Unknown

A Study of Autologous Induced Islet Body With Type 1 Diabetes

Type 1 Diabetes
Allife Medical Science and Technology Co., Ltd.

Unknown

A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke

Stroke, Ischemic
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Leukemia

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors

Liver Cancer

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Beijing Immunochina Medical Science & Technology...

Completed

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Leukemia

China
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Refractory B-Cell Lymphoma
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of Decitabine With R-GDP

NHL

China
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 Cells

Hematological Malignancies

China
Beijing Zheng Ju Medical Technology Co., Ltd.

Unknown

The Randomized Controlled Clinical Trial of Kushen Injection

Lung Cancer

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Novikang Medical Technology Co., LTD

Completed

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Hemophilia

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Leukemia

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma

Multiple Myeloma

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Melanoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

China
Beijing Immunochina Medical Science & Technology...

Recruiting

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

Hepatocellular Carcinoma , Cholangiocarcinoma

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Donor-derived CAR-T Cells in the Treatment of AML Patients

AML

China
Beijing Immunochina Medical Science & Technology...

Unknown

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Leukemia

China
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer
Allife Medical Science and Technology Co., Ltd.

Unknown

iHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations

Thalassemia
Allife Medical Science and Technology Co., Ltd.

Unknown

A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke

Stroke, Ischemic
Allife Medical Science and Technology Co., Ltd.

Unknown

Study of BCMA CAR-T in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma
Hangzhou Wei Qiang Medical Technology Co., Ltd.

Completed

Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access

Peripheral Vascular Diseases

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.; Beijing gene plus technology co., LTD

Completed

Apatinib in Refractory Colorectal Cancer

Colorectal Neoplasms

China
Overseas Pharmaceuticals, Ltd.
Guangzhou Kangqi Medical Technology Co., LTD

Not yet recruiting

Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition

Pain | Insomnia

China
Overseas Pharmaceuticals, Ltd.
Guangzhou Kangqi Medical Technology Co., LTD

Active, not recruiting

Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study

Hypertension

China
Nanjing NingQi Medicine Science and Technology...
Jiangsu Cancer Institute & Hospital

Unknown

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Peripheral T-cell Lymphomas

China
Harbin Medical University
Shanghai Shenqi Medical Technology Co., Ltd

Not yet recruiting

Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

Acute Coronary Syndrome (ACS)

China
Changhai Hospital
Wuxi Hisky Medical Technology Co Ltd

Not yet recruiting

Confocal Laser Microendoscopy (CellTouch) for the Diagnosis of Early Gastric Cancer: A Multicenter Clinical Study

Early Gastric Cancer

China
Tianjin Demax Medical Technology Co., Ltd
CEISO

Not yet recruiting

GUIDEX® Versus Launcher™ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR) (GUIDEX®_FR)

Coronary Artery Disease

France
Tongji Hospital
Wuhan Greenrhythm Medical Technology Co., LTD

Recruiting

Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture

Atrial Fibrillation

China
Safe Save Medical Cell Sciences & Technology Co...

Unknown

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

Taiwan
Resvent Holding USA LTD
Avania; Resvent Medical Technology Co., Ltd.

Not yet recruiting

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Peking Union Medical College Hospital
Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Recruiting

Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) (WU-KONG15)

Non Small Cell Lung Cancer

China
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Glioblastoma

China
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC

Hepatocellular Carcinoma

China
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Treatment of Carrying TP53 Harmful Mutations

Advanced Cancer

China
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Neoplasia

China
Tianjin Medical University General Hospital
Jiangsu Bioperfectus Technologies Co., Ltd

Not yet recruiting

Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining (VENUS)

Vaginal Infection
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)

Advanced Breast Cancer

China
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Early Breast Cancer

Clinical Trials Sponsored by Jiangsu Famous Medical Technology Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations